| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |